A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics
David Wonderling(Royal College of Physicians), Klim McPherson(University of Oxford), Penelope Hopwood, Fiona Douglas(University of Southern California), A. Cull, John Burn(Newcastle University), Maggie Watson(Royal Marsden NHS Foundation Trust)
Cited by 80
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.
|Journal of Clinical Oncology|1996|1.2k
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946